[Experimental studies in animals on the toxicity of fominoben-HCl]. 1974

G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008744 Methylamines Derivatives of methylamine (the structural formula CH3NH2).
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug

Related Publications

G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
November 1974, Arzneimittel-Forschung,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
January 1978, Arzneimittel-Forschung,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
January 1980, Arzneimittel-Forschung,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
January 1970, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
December 1972, Toxicology and applied pharmacology,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
July 1982, Sangyo igaku. Japanese journal of industrial health,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
April 2009, Homeopathy : the journal of the Faculty of Homeopathy,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
January 1979, Arzneimittel-Forschung,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
January 1957, Antibiotics annual,
G Pappritz, and M Bauer, and R Serbedija, and H Ueberberg
July 1982, Sangyo igaku. Japanese journal of industrial health,
Copied contents to your clipboard!